AR and blue cone monochromacy: For the overall follow-up period, the incidence of BCM for patients with AR+ tumors was half that of patients with AR− tumors in univariable Cox analyses (HR 0.48: 95% CI 0.30–0.77; P = 0.002, Table 2).